Optimal Angiographic Goal and Number of Passes for Octogenarians Undergoing Endovascular Stroke Thrombectomy

医学 冲程(发动机) 血管内治疗 放射科 外科 动脉瘤 机械工程 工程类
作者
Huanwen Chen,Marco Colasurdo,Chad Schrier,Jose Marino,Michael Phipps,Marcella A. Wozniak,Carolyn Cronin,Prachi Mehndiratta,John W. Cole,Timothy R. Miller,Jacob Cherian,Dheeraj Gandhi,Seemant Chaturvedi,Gaurav Jindal
出处
期刊:World Neurosurgery [Elsevier BV]
卷期号:186: e283-e289 被引量:3
标识
DOI:10.1016/j.wneu.2024.03.123
摘要

The optimal recanalization goal and number of endovascular thrombectomy (EVT) passes for elderly patients with large vessel occlusion (LVO) strokes is unclear.Consecutive patients 80 years or older undergoing EVT were identified from 2016 to 2022 at a single center. Clinical information, procedural details, and modified treatment in cerebral ischemia (mTICI) scores were collected. Primary outcome was modified Rankin scale (mRS) at 90 days. Bivariate and multivariable analyses were conducted to assess associations between mTICI scores, EVT passes, and 90-day outcomes.126 patients were identified. At 90 days, mTICI 2b recanalization resulted in high rates of poor outcomes (8.7% functional independence and 60.9% mortality) not significantly different from mTICI 0, 1 or 2a (median mRS 6 vs. 6, p=0.61). Complete recanalization (mTICI 2c or 3) led to significantly better mRS outcomes at 90 days compared to mTICI 2b (median mRS 4 vs. 6, adjusted p=0.038), with 26.8% functional independence and 37.8% mortality. In multivariable analysis, complete recanalization was significantly associated with better 90-day outcomes than mTICI 2b or lower recanalization (OR 4.24 [95%CI 1.46-12.3]; p=0.002), while the number of passes was not independently associated with worse outcomes (p=0.98).For octogenarians, mTICI 2b recanalization yields limited clinical benefit and results in poor 90-day outcomes. In contrast, complete recanalization is independently associated with significantly better outcomes. Thus, once the decision is made to pursue EVT in the elderly, mTICI 2c or better recanalization should be the angiographic goal. Providers should not withhold thrombectomy passes based on age alone.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
上好佳发布了新的文献求助10
刚刚
Lucas应助xiong采纳,获得10
刚刚
长夜变清早完成签到,获得积分10
刚刚
芜湖发布了新的文献求助10
1秒前
金甲狮王完成签到,获得积分10
2秒前
风趣月亮完成签到,获得积分10
2秒前
FashionBoy应助等待的音响采纳,获得10
2秒前
2秒前
意外的月饼完成签到,获得积分10
2秒前
3秒前
3秒前
赘婿应助谢书繁采纳,获得10
3秒前
科研通AI5应助sunrase采纳,获得10
4秒前
5秒前
研友_VZG7GZ应助芜湖采纳,获得10
5秒前
雷雷呀呀发布了新的文献求助10
5秒前
hyacinth完成签到,获得积分10
5秒前
fan完成签到,获得积分10
6秒前
dd发布了新的文献求助10
6秒前
6秒前
无花果应助HEIGE采纳,获得10
7秒前
打打应助Liskiat2021采纳,获得10
7秒前
fengcosky完成签到,获得积分10
7秒前
yunwen完成签到,获得积分10
8秒前
科研通AI5应助清水采纳,获得10
8秒前
AAAAA发布了新的文献求助10
8秒前
8秒前
斑鸠津完成签到,获得积分10
9秒前
小小发布了新的文献求助10
9秒前
吉吉驳回了所所应助
9秒前
单于笑卉完成签到,获得积分10
9秒前
Xltox完成签到,获得积分10
10秒前
982289172发布了新的文献求助10
10秒前
现代的黄豆完成签到,获得积分10
11秒前
jiang_tian完成签到,获得积分10
11秒前
一一应助guoyuheng采纳,获得30
11秒前
xiong完成签到,获得积分10
11秒前
12秒前
单于笑卉发布了新的文献求助10
13秒前
高分求助中
All the Birds of the World 1000
IZELTABART TAPATANSINE 500
GNSS Applications in Earth and Space Observations 300
Armour of the english knight 1400-1450 300
Handbook of Laboratory Animal Science 300
Not Equal : Towards an International Law of Finance 260
Beginners Guide To Clinical Medicine (Pb 2020): A Systematic Guide To Clinical Medicine, Two-Vol Set 250
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3714817
求助须知:如何正确求助?哪些是违规求助? 3262044
关于积分的说明 9921972
捐赠科研通 2975738
什么是DOI,文献DOI怎么找? 1631855
邀请新用户注册赠送积分活动 774178
科研通“疑难数据库(出版商)”最低求助积分说明 744742